Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome. 2007

Frode S Berven, and Ann C Kroksveen, and Magnus Berle, and Tarja Rajalahti, and Kristian Flikka, and Reidar Arneberg, and Kjell-Morten Myhr, and Christian Vedeler, and Olav M Kvalheim, and Rune J Ulvik
Institute of Medicine, University of Bergen, Bergen, Norway. Frode.Berven@biomed.uib.no.

Cerebrospinal fluid (CSF) is a perfect source to search for new biomarkers to improve early diagnosis of neurological diseases. Standardization of pre-analytical handling of the sample is, however, important to obtain acceptable analytical quality. In the present study, MALDI-TOF MS was used to examine the influence of pre-analytical sample procedures on the low molecular weight (MW) CSF proteome. Different storage conditions like temperature and duration or the addition of as little as 0.2 µL blood/mL neat CSF caused significant changes in the mass spectra. The performance of different types of MW cut-off spin cartridges from different suppliers used to enrich the low MW CSF proteome showed great variance in cut-off accuracy, stability and reproducibility. The described analytical method achieved a polypeptide discriminating limit of approximately 800 pM, two to three orders of magnitude lower than reported for plasma. Based on this study, we recommend that CSF is centrifuged immediately after sampling, prior to storage at -80ºC without addition of protease inhibitors. Guanidinium hydrochloride is preferred to break protein-protein interactions. A spin cartridge with cut-off limit above the intended analytical mass range is recommended. Our study contributes to the important task of developing standardized pre-analytical protocols for the proteomic study of CSF.

UI MeSH Term Description Entries

Related Publications

Frode S Berven, and Ann C Kroksveen, and Magnus Berle, and Tarja Rajalahti, and Kristian Flikka, and Reidar Arneberg, and Kjell-Morten Myhr, and Christian Vedeler, and Olav M Kvalheim, and Rune J Ulvik
October 2019, Clinica chimica acta; international journal of clinical chemistry,
Frode S Berven, and Ann C Kroksveen, and Magnus Berle, and Tarja Rajalahti, and Kristian Flikka, and Reidar Arneberg, and Kjell-Morten Myhr, and Christian Vedeler, and Olav M Kvalheim, and Rune J Ulvik
January 2010, Journal of proteomics,
Frode S Berven, and Ann C Kroksveen, and Magnus Berle, and Tarja Rajalahti, and Kristian Flikka, and Reidar Arneberg, and Kjell-Morten Myhr, and Christian Vedeler, and Olav M Kvalheim, and Rune J Ulvik
May 2013, Journal of neuroscience methods,
Frode S Berven, and Ann C Kroksveen, and Magnus Berle, and Tarja Rajalahti, and Kristian Flikka, and Reidar Arneberg, and Kjell-Morten Myhr, and Christian Vedeler, and Olav M Kvalheim, and Rune J Ulvik
March 1973, Journal of neurochemistry,
Frode S Berven, and Ann C Kroksveen, and Magnus Berle, and Tarja Rajalahti, and Kristian Flikka, and Reidar Arneberg, and Kjell-Morten Myhr, and Christian Vedeler, and Olav M Kvalheim, and Rune J Ulvik
September 2015, Clinica chimica acta; international journal of clinical chemistry,
Frode S Berven, and Ann C Kroksveen, and Magnus Berle, and Tarja Rajalahti, and Kristian Flikka, and Reidar Arneberg, and Kjell-Morten Myhr, and Christian Vedeler, and Olav M Kvalheim, and Rune J Ulvik
November 2021, Diagnostics (Basel, Switzerland),
Frode S Berven, and Ann C Kroksveen, and Magnus Berle, and Tarja Rajalahti, and Kristian Flikka, and Reidar Arneberg, and Kjell-Morten Myhr, and Christian Vedeler, and Olav M Kvalheim, and Rune J Ulvik
August 2007, Proteomics. Clinical applications,
Frode S Berven, and Ann C Kroksveen, and Magnus Berle, and Tarja Rajalahti, and Kristian Flikka, and Reidar Arneberg, and Kjell-Morten Myhr, and Christian Vedeler, and Olav M Kvalheim, and Rune J Ulvik
April 2007, Journal of proteome research,
Frode S Berven, and Ann C Kroksveen, and Magnus Berle, and Tarja Rajalahti, and Kristian Flikka, and Reidar Arneberg, and Kjell-Morten Myhr, and Christian Vedeler, and Olav M Kvalheim, and Rune J Ulvik
January 1984, Medical and pediatric oncology,
Frode S Berven, and Ann C Kroksveen, and Magnus Berle, and Tarja Rajalahti, and Kristian Flikka, and Reidar Arneberg, and Kjell-Morten Myhr, and Christian Vedeler, and Olav M Kvalheim, and Rune J Ulvik
August 1990, Biochemical pharmacology,
Copied contents to your clipboard!